Alebund Pharmaceuticals Files HKEX Next-Day Return Disclosing Share BuybackPUBT·Nov 16, 2026 at 11:43 AM096370.00%
Alebund Pharmaceuticals Reports Share Buyback in HKEX Next-Day Disclosure ReturnPUBT·Nov 13, 2026 at 02:02 PM096370.00%
Alebund Pharmaceuticals Discloses Share Buyback in HKEX Next-Day ReturnPUBT·Nov 5, 2026 at 02:05 PM096370.00%
Alebund Pharmaceuticals files next-day disclosure return with HKEX announcing share buybackPUBT·Nov 4, 2026 at 02:08 PM096370.00%
Alebund Pharmaceuticals Files HKEX Next Day Disclosure Return Announcing Share BuybackPUBT·Nov 3, 2026 at 02:03 PM096370.00%
Alebund Pharmaceuticals Files Next-Day Disclosure With HKEX on Share RepurchasePUBT·Nov 2, 2026 at 02:04 PM096370.00%
Weekly Recap | ALEBUND-B -10.81%, most brokers rate it buyWeekly Review·Oct 24, 2026 at 05:46 AM096370.00%
Alebund Partner R1 Presents Phase IIb Trial Design for AP306 in HyperphosphatemiaPUBT·Oct 23, 2026 at 11:01 AM096370.00%
Why Hong Kong's Small Caps Are Priced by Deals, Not ProductsGlobal Report·Oct 13, 2026 at 10:50 AM00975-3.35%02507-1.01%
Hong Kong Consumer Stocks Outperform as Property Services Firms Report LossesGlobal Report·Oct 13, 2026 at 09:24 AM00887-1.89%01855-6.98%
Weekly Recap | ALEBUND-B flat, choppy week on heavy volumeWeekly Review·Oct 10, 2026 at 05:56 AM096370.00%